Results 11 to 20 of about 12,086 (232)

Rare Conditions of Candidemia: Risk Factors and Outcomes for Mixed Candidemia and Late Recurrent Candidemia

Mediterranean Journal of Infection, Microbes and Antimicrobials
Introduction: Mixed candidemia (MC) and late recurrent candidemia (LRC) are rare conditions. Studies on these issues are limited. Our aim was to investigate the characteristics, risk factors, and outcomes of these rare conditions. Materials and Methods:
Bahadır Orkun ÖZBAY, Aliye BAŞTUĞ, Ömer AYDOS, Nizamettin KEMİRTLEK, Derya GÖKÇINAR, Bedia DİNÇ, Hürrem BODUR   +6 more
doaj   +2 more sources

Active Surveillance of Candidemia, Australia [PDF]

Emerging Infectious Diseases, 2006
Population-based surveillance for candidemia in Australia from 2001 to 2004 identified 1,095 cases. Annual overall and hospital-specific incidences were 1.81/100,000 and 0.21/1,000 separations (completed admissions), respectively. Predisposing factors included malignancy (32.1%), indwelling vascular catheters (72.6%), use of antimicrobial agents (77%),
Sharon Chen, Monica A. Slavin, Quoc Nguyen, Deborah Marriott, E. Geoffrey Playford, David Ellis, Tania C. Sorrell   +6 more
openalex   +6 more sources

Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States. [PDF]

Mycoses
ABSTRACT Background Rezafungin, a novel echinocandin with once‐weekly intravenous dosing, offers potential advantages for outpatient parenteral antifungal therapy (OPAT) in invasive candidiasis (IC). While clinical trial data support its efficacy and safety, real‐world experience remains limited.
Reinhold I, Mori G, Lanzafame M, Limongelli A, Vena A, Götz J, Bauernfeind S, Hanses F, Tometten L, Mayer M, Rieke A, Soriano-Martin A, Valerio M, Vazquez JA, Yue P, Rahimli L, Azimli N, Sal E, Salmanton-García J, Vasenda N, Sprute R, Stemler J, Wingen-Heimann S, Cornely OA, Seidel D.   +24 more
europepmc   +2 more sources

Epidemiology of Candidemia [PDF]

Journal of Clinical Microbiology, 2008
We read with great interest the article by Colombo et al. ([1][1]). The findings are very interesting and very useful for Brazilian doctors, especially with respect to the frequency of antifungal resistance. We have some questions on the clinical methodology.
Renato S. Procianoy, Rita de Cássia dos Santos Silveira   +1 more
openaire   +3 more sources

Ocular Manifestations of Candidemia [PDF]

Clinical Infectious Diseases, 2011
Ocular candidiasis is a major complication of candidemia. The incidence, risk factors, and outcome of eye involvement during candidemia are largely unknown. We prospectively studied the ocular manifestations of candidemia in a large, worldwide, randomized multicenter trial that compared voriconazole with amphotericin B followed by fluconazole for the ...
Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, VISCOLI, CLAUDIO, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ   +9 more
openaire   +3 more sources

Evaluating the Prognostic Value of the EQUAL Candida Score and a Nomogram-Based Approach for Candidaemia-Related Mortality. [PDF]

Mycoses
ABSTRACT Introduction Candidaemia is a life‐threatening infection with a persistently high mortality rate, despite significant advances in antifungal therapy and supportive care. The European Confederation of Medical Mycology developed the EQUAL Candida Score as a standardised tool to evaluate adherence to guideline‐based management; however, its ...
Saricaoglu EM, Hekimoglu MI, Gulten E, Akdemir I, Cinar G, Yilmaz AZ, Ocal D, Kar I, Memikoglu KO, Yoruk F.   +9 more
europepmc   +2 more sources

Candidemia en Colombia

Biomédica, 2020
En Colombia, especialmente en las unidades de cuidados intensivos, la candidemia es una causa frecuente de infección del torrente sanguíneo y representa el 88 % de lasinfecciones fúngicas en pacientes hospitalizados, con una mortalidad entre 36 y 78 %.
Cortés, Jorge Alberto, Ruiz, José Franklin, Melgarejo-Moreno, Lizeth Natalia, Lemos, Elkin V.   +3 more
openaire   +6 more sources

Persistent candidemia in very low birth weight neonates: risk factors and clinical significance

BMC Infectious Diseases, 2018
Background The prevalence and risk factors for persistent candidemia among very low birth weight infants are poorly understood. This study aimed to investigate the epidemiology of persistent candidemia over a 4-year period in a neonatal intensive care ...
Jinjian Fu, Yanling Ding, Yongjiang Jiang, Shengfu Mo, Shaolin Xu, Peixu Qin   +5 more
doaj   +1 more source

Risk factors for candidemia: A case–control study

Antimicrobial Stewardship & Healthcare Epidemiology, 2022
Background: Candida bloodstream infections (candidemia) have significant mortality and morbidity rates, as well as healthcare cost implications. Emerging multidrug-resistant Candida spp such as Candida auris, as well as increasing resistance among non ...
Serin Edwin Erayil, Katelyn Tessier, Susan Kline   +2 more
doaj   +1 more source

Risk Factors and Clinical Outcomes of Candidemia Associated With Severe COVID-19

Critical Care Explorations, 2022
IMPORTANCE:. COVID-19 can cause serious illness requiring multimodal treatment and is associated with secondary infections. Studies have suggested an increased risk of fungal infections, including candidemia following severe COVID-19 though understanding
Deepali Dixit, PharmD, BCPS, BCCCP, FCCM, Polly Jen, PharmD, BCPS, BCIDP, AAHIVP, Tyler D. Maxwell, BS, PharmD, Steven Smoke, PharmD, BCPS, BCIDP, James Andrew McCracken, PharmD, Maria Cardinale-King, PharmD, BCCCP, Aditi Haribhakti, PharmD Candidate, Purvi Patel, MD, Eris Cani, BS, PharmD, BCIDP, BCPS, Seohyun (Claudia) Choi, PharmD, BCCCP, Sugeet Jagpal, MD, Tilly Varughese, MD, Luis L. Tatem, MD, Tanaya Bhowmick, MD   +13 more
doaj   +1 more source